Treatment of advanced prostate cancer ARAMIS
This Medudy course is a video tutorial for physicians on the topic of "Treatment of advanced prostate cancer: The ARAMIS study." Prof. Dr. Martin Bögemann, senior physician for urology and pediatric urology at Münster University Hospital, presents the ARAMIS study investigating the efficacy and safety of darolutamide in non-metastatic, castration-resistant prostate cancer. Note: All "speakers" appearing in the Medudy videos are [...]
Treatment of advanced prostate cancer DDI during ARPI administration
This Medudy course is a video tutorial for physicians on the topic of "Drug-drug interactions (DDIs) during ARPI administration in the context of advanced prostate cancer therapy." Prof. Axel Merseburger, Director of the Department of Urology at the Lübeck Campus of the University Medical Center Schleswig-Holstein, presents the current evidence and clinical relevance of this topic. This is of particular importance because the [...]
Expert update: Cervical cancer
This Medudy course is a five-part video series for physicians on the topic of "Cervical Cancer Update." In part 1 of the series, we begin with the topic of lymphadenectomy in early cervical cancer. Part 2 then deals with the prognosis of locally advanced cervical cancer, before we take a look at the treatment of locally advanced cervical cancer in part 3. […]
MoonRISe-3: TAR-210 in high-risk non-muscle-invasive bladder cancer
This Medudy course is a video tutorial for physicians on the topic of "MoonRISe-3: TAR-210 in high-risk non-muscle-invasive bladder cancer (NMIBC)". High-risk NMIBC is one of the most clinically challenging entities in urology. Despite standard intravesical therapies such as BCG or chemotherapy, recurrence and progression rates remain high, so that in many cases radical cystectomy is ultimately the only treatment option [...].
Quality of care for locally advanced and metastatic urothelial carcinoma in Germany
This Medudy course is a video tutorial for physicians on the topic of "Quality of care for locally advanced and metastatic urothelial carcinoma in Germany." Prof. Dr. Carsten Ohlmann, Chief Physician of the Department of Urology at the Johanniter-Kliniken Bonn, presents real treatment data and recommendations for guideline-based care. The course highlights the therapeutic challenges of locally advanced and metastatic urothelial carcinoma, [...]
Lp(a) as a cardiovascular risk factor
This Medudy course is a five-part video series for physicians on the topic of "Lp(a) as a cardiovascular risk factor." We begin with a brief introduction to the background and relevance of the topic. Part 1 then deals with Lp(a) as an independent, causally genetically determined cardiovascular risk factor. In Part 2, we then focus on the structure of the Lp(a) molecule [...].
Arterial hypertension
This Medudy Master Class Series is a video tutorial for physicians on nephrological topics. This two-part module focuses on arterial hypertension and is presented by Prof. Dr. Jan-Christoph Galle, Director of the Clinic for Nephrology and Dialysis at Lüdenscheid Hospital. The first part of the course provides an overview of arterial hypertension from a nephrological perspective [...].
Test Course
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, [...]
Part 6 Therapy management of antibody-drug conjugates (ADC)
This Medudy Master Class Series with Prof. Sherko Kümmel is a video tutorial for physicians on the topic "Therapy of Triple-Negative Breast Cancer". Part 6 of the tutorial focuses on the therapy management of antibody-drug conjugates (ADC). The focus is on the use and handling of substances such as sacituzumab-govitecan and trastuzumab-deruxtecan. The tutorial also provides [...]
Part 5 Metastatic TNBC
This Medudy Expert Opinion with Prof. Sherko Kümmel is a video tutorial for physicians on the topic of "Treatment of metastatic triple-negative breast cancer (TNBC)". The content first highlights the historical situation in 2018, in which the prognosis for high-risk tumor biology was very poor and the median overall survival time was only 12 to 15 months. The [...]